NHS approves weight loss drug Mounjaro
The groundbreaking diabetes treatment Mounjaro receives NHS approval for weight management, offering new hope for millions struggling with obesity in the UK.
The groundbreaking diabetes treatment Mounjaro receives NHS approval for weight management, offering new hope for millions struggling with obesity in the UK.
The groundbreaking diabetes medication Mounjaro is transforming weight management across Britain, but availability and cost remain significant barriers for patients seeking its benefits.
Exclusive investigation reveals criminals are selling fake versions of powerful diabetes drugs retatrutide and tirzepatide as weight loss treatments, putting thousands at risk.
A UK mother's life was transformed when a diabetes medication unexpectedly eliminated her severe obsessive-compulsive disorder, in what doctors are calling a remarkable medical breakthrough.
Groundbreaking research reveals Mounjaro injections could revolutionise obesity treatment by targeting food addiction mechanisms in the brain, offering new hope for millions struggling with compulsive eating.
A 35-year-old woman shares her incredible 5-stone weight loss journey using diabetes drug Mounjaro, revealing the uncomfortable side effect affecting thousands and the cheap gadget that provided relief.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
A determined mother from the UK has shed over 10 stone using diabetes medication Mounjaro, completely transforming her life and health in an inspiring weight loss journey.
Medical experts reveal why the popular diabetes and weight loss medication Mounjaro is causing unexpected libido problems in some patients, and what you need to know about this concerning side effect.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
The NHS launches a new front in the fight against obesity, making the potent weight-loss drug Mounjaro available to thousands. Health Secretary Wes Streeting hails the move as a pivotal shift towards prevention.
Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
The NHS in England launches a major new weapon against obesity, making the potent Mounjaro injection available to thousands through a specialist weight management service.
The NHS in England is set to rollout the powerful weight-loss injection Mounjaro (tirzepatide) through GP prescriptions, following a landmark NICE approval that could transform obesity treatment.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Exclusive: Desperate UK diabetics face a devastating health crisis as they are cut off from the 'miracle' weight-loss drug Mounjaro (tirzepatide) due to soaring costs and an NHS postcode lottery, with patients fearing for their lives.
A British mother's life-changing journey from 30st to 8st using diabetes drug Mounjaro. Discover how this remarkable transformation saved her marriage and restored her health against all odds.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
An NHS administrator reveals how she lost four stone using a controversial cost-cutting method to obtain diabetes drug Mounjaro for weight loss, as doctors issue serious safety warnings.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
Shocking new data reveals a stark postcode lottery for the diabetes and weight loss drug Mounjaro (tirzepatide) in England, with patients in some areas almost completely unable to access it on the NHS despite being eligible.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
The NHS in England is set to provide the weight-loss drug Mounjaro (tirzepatide) to thousands, following a landmark deal that could save millions and free up GP capacity.